Research use only · Multi-region fulfillment · Support-assisted ordering
VestaResearch Supply
Oseltaflu 75mg Tablets | 100-Count | OSELTAMIVIR
Pharma

Oseltaflu 75mg Tablets | 100-Count | OSELTAMIVIR

$160

In stock

For in vitro laboratory research only. Not for human or veterinary consumption.

India Warehouse OSELTAMIVIR — 75mg per tablet, 100-count pack. Neuraminidase inhibitor for treatment and prevention of influenza A and B. Most effective within 48 hours of symptom onset. Used in post-exposure prophylaxis and immunocompromised patients. Key warning: Reduced dose in renal impairment. Monitor neuropsychiatric symptoms especially in pediatric patients. Live attenuated influenza vaccine may be less effective within 2 weeks of oseltamivir.

SKU
VES-000817-OSELTAFL-75MG-100TAB
Format
N/A
Use
Laboratory research only
Ask on Telegram

What is Oseltaflu 75mg (OSELTAMIVIR)?

Neuraminidase inhibitor for treatment and prevention of influenza A and B. Most effective within 48 hours of symptom onset. Used in post-exposure prophylaxis and immunocompromised patients.

How it Works

Inhibits influenza neuraminidase — prevents viral release from infected cells and reduces spread. Reduces severity and duration by approximately 1–2 days when started early.

Quick Specs

Form
Oral tablets — pre-dosed
Active Ingredient
OSELTAMIVIR
Dose per Tablet
75MG
Pack Size
10×10 (100 tablets)
Storage
Room temperature (15–25°C), cool dry place
Shelf Life
2–3 years (properly stored)

Common Side Effects

Nausea and vomiting — take with food. Headache. Rare neuropsychiatric events especially in children.

Safety Warnings

Reduced dose in renal impairment. Monitor neuropsychiatric symptoms especially in pediatric patients. Live attenuated influenza vaccine may be less effective within 2 weeks of oseltamivir. International shipping: 7–14 days

Research use only

This material is supplied strictly for in vitro laboratory research. It is not intended for human or veterinary consumption, diagnosis, treatment, or household use.